Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about OCUL

Recent news which mentions OCUL

< Previous 1 2 3 4 5 Next >
Recap: Ocular Therapeutix Q2 Earnings
Tickers OCUL
Tags OCUL Benzinga Market News
From Benzinga
Earnings Scheduled For August 8, 2022
Tickers MRSN MX NCMI NE
Tags TTCF NNI NRGV
From Benzinga
Stocks That Hit 52-Week Lows On Friday
Tickers ACB AERI AGIO ALBO
Tags EPIX MF GEHI
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tickers NRIX NRXP NTNX OCCI
Tags TKNO PSHG SECO
From Benzinga
Expert Ratings for Ocular Therapeutix
Tickers OCUL
Tags Market News Benzinga Analyst Ratings
From Benzinga
Earnings Scheduled For May 9, 2022
Tickers IFF III IIIV ITUB
Tags TGNA IFF MEG
From Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Tickers ACAD AQST BIIB BLTE
Tags Guidance Financing Small Cap
From Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Tickers AGTC AMGN AMRN ATHX
Tags IMMP IMGN PFE
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tickers ACON ALNA BLRX CABA
Tags JSPR CABA Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tickers HLBZ HNST HYFM HYRE
Tags PGEN OYST JSPR
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Tickers ACLX ADVM AFCG ALLK
Tags MSGM MORF FCRD
From Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Tickers ABT ANTX GSK IBB
Tags TGTX ISRG Covid/19
From Benzinga
Recap: Ocular Therapeutix Q4 Earnings
Tickers OCUL
Tags Earnings Market News Benzinga
From Benzinga
Earnings Scheduled For February 28, 2022
Tickers AAON ACAD ACHC AGM
Tags DNMR AMRC SAIL
From Benzinga
Stocks That Hit 52-Week Lows On Friday
Tickers LAWS LAZ LII LOVE
Tags RERE PMT MRKR
From Benzinga
Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial
Tickers OCUL
Tags dry eye disease Briefs Phase 2 Trial
From Benzinga
3 Small-Cap Stocks to Buy Now and Hold for the Long Haul
Tickers NNOX OCUL RNLX
Tags OCUL RNLX Market News
From Motley Fool
Expert Ratings For Ocular Therapeutix
Tickers OCUL
Tags OCUL BZI/AAR Analyst Ratings
From Benzinga
Ocular Therapeutix Stock Gains As Court Invalidates Drug Delivery Patent From Mati
Tickers OCUL
Tags Long Ideas Trading Ideas Movers
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tickers ABSI ACAD ASRT CMPS
Tags ACAD OCUL ABSI
From Benzinga
Ocular Therapeutix: Q3 Earnings Insights
Tickers OCUL
Tags OCUL Benzinga Market News
From Benzinga
Earnings Scheduled For November 8, 2021
Tickers GPMT GTES GWRS HIL
Tags RCUS PRAA Earnings
From Benzinga
What 5 Analyst Ratings Have To Say About Ocular Therapeutix
Tickers OCUL
Tags Analyst Ratings Benzinga Market News
From Benzinga
How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More
Tickers AVIR BBIG GRTX MTCR
Tags Movers BBIG Trading Ideas
From Benzinga
10 Biggest Price Target Changes For Monday
Tickers BAC BJRI CCL MSFT
Tags Price Target Changes VIR ORCL
From Benzinga
55 Biggest Movers From Friday
Tickers AGEN ALTM AUPH BBIG
Tags PHUN Movers CRTD
From Benzinga
Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?
Tickers AGEN AVIR BMY DWAC
Tags RHHBY SHIB TSLA
From Motley Fool
Mid-Afternoon Market Update: Nasdaq Down 70 Points; Ocular Therapeutix Shares Drop
Tickers AXP CRTD DWAC MTCR
Tags Markets Commodities PHUN
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Tickers AGEN ARAY BFRA BPTS
Tags Top Gainers Markets BFRA
From Benzinga
Mid-Day Market Update: Snap Drops After Q3 Results; Creatd Shares Jump
Tickers AXP CRTD DWAC MTCR
Tags CRTD Earnings AXP
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.